DSM-Firmenich agrees to sell animal health unit to CVC Capital for 2.2 billion euros
DSM-Firmenich will sell its animal health unit to CVC Capital for 2.2 billion euros. The move completes its transition into a focused consumer health company.
Insights:
DSM-Firmenich AG has reached an agreement to sell its Animal Nutrition & Health business to CVC Capital Partners plc for an enterprise value of approximately €2.2 billion. The deal, which includes the company's feed enzymes activities, will see DSM-Firmenich AG receive roughly €1.2 billion in upfront cash proceeds. In addition to the initial payment, the company will retain a 20% stake in the business and may receive a potential earn-out of up to €500 million.
The divestment is presented by the company as the final step in its move to become a fully focused consumer company. In conjunction with the deal, DSM-Firmenich AG has announced a planned €500 million share buyback to be executed in the first quarter of 2026. The transaction with CVC Capital Partners plc is currently expected to close at the end of 2026.
